VP, Head of Biometrics

About the role

TScan is seeking an accomplished and strategic Vice President, Biostatistics to lead all biometric activities across the company's clinical development portfolio, including multiple ongoing and planned studies supporting the advancement of TCR-T cell therapies for patients with cancer.

Responsibilities

• Establish and lead the biostatistics strategy across TScan's clinical development portfolio, from Phase 1 to registrational and post-registration studies.
• Provide statistical leadership and strategic guidance to executive management on development plans, clinical study design, endpoint selection, estimands, and data interpretation.
• Contribute to portfolio strategy, lifecycle management planning, and business development evaluations.
• Serve as a trusted advisor to senior leadership on benefit-risk assessments and key development decisions.
• Lead statistical design and analysis planning for all clinical studies.
• Oversee development of protocols, statistical analysis plans (SAPs), clinical study reports (CSRs), integrated summaries, and regulatory submission documents.
• Drive statistical strategy for complex cell therapy clinical programs, including durability analyses, long-term follow-up, safety monitoring, and innovative endpoint development.
• Represent Biostatistics in interactions with FDA, EMA, and other global regulatory agencies.
• Provide leadership for regulatory submissions, including BLA and international marketing applications.
• Ensure all statistical deliverables are scientifically sound and aligned with global regulatory expectations.
• Build and lead a high-performing biostatistics organization.
• Oversee external CROs, statistical programming partners, and consultants to ensure quality, efficiency, and compliance.
• Establish and continuously improve departmental processes, standards, and quality systems.
• Foster a culture of scientific excellence, innovation, collaboration, and accountability.
• Partner with Clinical Development to optimize study designs and interpret emerging clinical data.
• Collaborate closely with Data Management and Statistical Programming teams to ensure high-quality and timely analyses.
• Support Medical Affairs, Publications, and Investor Relations through statistical interpretation and communication of clinical results.
• Present statistical findings and strategic recommendations to senior leadership, Board members, and external stakeholders.

Requirements

• PhD in Biostatistics, Statistics, or a related quantitative discipline required.
• Minimum of 15 years of biostatistics experience in biotechnology, pharmaceutical, or related industries.
• Significant leadership experience managing biostatistics organizations in a clinical development environment.
• Demonstrated success leading statistical strategy for pivotal clinical trials and regulatory submissions.
• Experience supporting BLA, NDA, MAA, or equivalent regulatory filings.
• Experience in oncology and advanced therapies, including cell therapy, TCR-T, CAR-T, gene therapy, or immuno-oncology strongly preferred.
• Strong understanding of global regulatory requirements and evolving statistical expectations in advanced therapeutic modalities.
• Deep expertise in clinical trial design, survival analysis, longitudinal data analysis, multiplicity control, estimands, missing data methodologies, and adaptive designs.
• Strong knowledge of FDA, EMA, ICH, and CDISC standards.
• Experience overseeing statistical programming and integrated analyses.
• Familiarity with innovative trial designs and analytical approaches relevant to cellular therapies.
• Strategic and enterprise-minded leader with strong business acumen.
• Excellent communication skills with the ability to influence diverse stakeholders.
• Proven ability to build and scale high-performing teams in a fast-paced biotechnology environment.
• Strong executive presence and ability to communicate complex statistical concepts to both technical and non-technical audiences.
• Collaborative leader who thrives in highly cross-functional organizations.

About TScan

TScan Therapeutics is a fully integrated, next-generation TCR-T cell therapy company. Founded in 2018, TScan’s platform was developed by Stephen Elledge, Ph.D., and Tomasz Kula, Ph.D., at Brigham and Women’s Hospital and Harvard Medical School. TScan’s transformative platform enables rapid discovery of TCRs and targets for engineered T cell therapy. This technology is extremely versatile and is applicable across multiple therapeutic areas beyond cancers, including autoimmune disorders and infectious diseases.

EEO Statement

TScan is proud to be an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, citizenship status, sexual orientation, gender identity or expression, or any other characteristic identified by federal, state, or local laws where we operate. TScan provides reasonable accommodations to qualified applicants and employees with disabilities. To begin an interactive dialogue with TScan regarding a reasonable accommodation in connection with the hiring process and/or to perform the responsibilities of the position for which the applicant has applied, please contact the recruiter.

Pay Range

$340,000 - $380,000